Expression of urokinase-type plasminogen activator in an experimental model of hepatocarcinoma

Toxicology

Volumn 161, Issue 1-2, 2001, Pages 13-23

  Nieto Rodríguez, Alejandro ^a,c   Hernandez Pando R ^a   Kershenobich, D ^a   Rodriguez Fragoso L ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Hepatocarcinogenesis; Immunohistochemical; Urokinase type plasminogen activator

Indexed keywords

CARCINOGEN; GAMMA GLUTAMYLTRANSFERASE; UROKINASE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME KINETICS; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MALIGNANT TRANSFORMATION; METASTASIS; MORPHOLOGY; NODULAR HYPERPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE SECTION; TUMOR VASCULARIZATION;

ANIMALS; BODY WEIGHT; CARCINOMA, HEPATOCELLULAR; GAMMA-GLUTAMYLTRANSFERASE; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MODELS, BIOLOGICAL; ORGAN SIZE; PLASMINOGEN ACTIVATORS; RATS; RATS, WISTAR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035925626     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(00)00404-2     Document Type: Article

References (36)

1. Urokinase-type plasminogen activator: Proenzyme, receptor and inhibitor
2. Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumors
3. Differential diagnosis between hepatocellular carcinoma and cirrhosis through a discriminant function based on results for serum analytes
4. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells
5. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression
6. Plasminogen activators, tissue degradation and cancer
7. Activation, proliferation, and differentiation of progrenitor cells into hepatocytes in D-galactosamine model of liver regeneration
8. Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver
9. Multistage rodent hepatocarcinogenesis
10. Hepatocellular carcinoma
11. Gamma-glutamyl transpeptidase, a glutationase: Its expression and function in carcinogenesis
12. Hepatocellular carcinoma
13. Gamma-glutamyl transpeptidase mediation of tumor glutathione utilization in vivo
14. A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA
15. Urokinase-type plasminogen activator (uPA) antigen is a predictor of early relapse in breast cancer
16. Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer
17. A role of urokinase type plasminogen activator (uPA) in invasion and growth of hepatocellular cancer cells in vitro
18. Expression of urokinase type plasminogen activator receptor and plasminogen activator inhibitor-1 in gastric cancer
19. Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis
20. The relevance of plasminogen activator to neoplastic growth - A review of recent literature
21. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies
22. Cancer of the liver
23. Hepatocarcinogenesis in the rat: The effect of promoters and carcinogens in vivo and in vitro
24. Cancers of the gastrointestinal tract
25. Hepatocellular carcinoma
26. In vivo invasion of modified chorioallantoic membrane by tumor cells: The role of cell surface bound urokinase
27. Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadriavirus infection and clonal growth of hepatocellular carcinoma
28. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
29. Physioanatomic considerations
30. Tumor-associated proteases
31. New principle for the analysis of chemical carcinogenesis
32. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro
33. Regional variations of urokinase type plasminogen activator in human colorectal cancer: A quantitative study by image analysis
34. Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor a plasminogen activator
35. Serum gammaglutamyl transpeptidase activity in liver disease